Skip to main content
. 2019 Oct 16;14(10):e0223769. doi: 10.1371/journal.pone.0223769

Table 7. Costs (RMB) of standard treatments with anti-diabetic LPGs.

Generics Dosage per day
(mg)
Median price per mg Cost for a duration Day’s wages to pay for treatment for urban residents Day’s income to pay for treatment for rural residents
Public Private Public Private Public Private P* Public Private P*
Acarbose 150 0.034 0.028 153 126.0 3.46 2.85 0.81 7.02 5.78 0.72
Glibenclamide 5 0.007 0.008 1.05 1.2 0.02 0.03 0.05 0.06
Gliclazide
(30 mg)
30 0.017 0.021 15.3 18.9 0.35 0.43 0.70 0.87
Gliclazide (80 mg) 80 0.003 0.004 7.2 9.6 0.16 0.22 0.33 0.44
Glimepiride 2 0.610 0.625 36.6 37.5 0.83 0.85 1.38 1.72
Glipizide 5 0.086 0.090 12.9 13.5 0.26 0.31 0.59 0.62
Metformin 1000 0.0005 0.001 15.0 30.0 0.34 0.68 0.69 1.38
Pioglitazone 30 0.146 0.162 131.4 145.8 2.98 3.30 6.03 6.69
Repaglinide 2 1.380 1.327 82.8 79.62 1.87 1.80 3.80 3.65
Mean 0.25 0.25 50.56 51.35 1.15 1.16 2.32 2.36

*: paired t tests.